Review is set up after doctors fail to disclose industry funding

Lenzer, Jeanne
June 2008
BMJ: British Medical Journal (International Edition);6/14/2008, Vol. 336 Issue 7657, p1327
Academic Journal
The article reports on an investigation of the finances of a Harvard University professor of psychiatry and two colleagues which was led by U.S. senator Charles Grassley. The investigation revealed that the professor, Joseph Biederman, and his colleagues, Thomas Spencer and Timothy Wilens, failed to report millions of dollars of payments that they had received from pharmaceutical companies. A discussion of the problems the investigation results have caused for Harvard Medical school and the U.S. National Institutes of Health is presented.


Related Articles

  • Pharma payment probe widens its net. Wadman, Meredith // Nature;10/23/2008, Vol. 455 Issue 7216, p1017 

    The article reports on U.S. Senator Charles Grassley's investigation of psychiatrists that failed to declare payments from drug companies in 2000-2007. Grassley claimed that these academic researchers, including Joseph Biederman, Melissa Delbello and Charles Nemeroff, failed to report to their...

  • Changing how college works. Shaw, Jane S. // Liberty (08941408);Apr2008, Vol. 22 Issue 3, p18 

    The author talks about endowments given to top-rated U.S. universities wherein higher education authorities have observed a breach in its usage. Republican Senator Charles Grassley from Iowa has warned the universities of penalty if they do not use the endowments properly. To this end, Harvard...

  • Ethical and Moral Obligations Arising From Revelations of Pharmaceutical Company Dissembling. Gottstein, James B. // Ethical Human Psychology & Psychiatry;2010, Vol. 12 Issue 1, p22 

    The article reports on pharmaceutical companies' fraud and manipulation and their impact on psychiatrists, psychologists, and social workers' ethical obligation. U.S. Senator Charles Grassley has reportedly exposed psychiatric opinion leaders for secretly and illegally taking large sums of money...

  • Senator asks US psychiatrists' group about drug company funding. Tanne, Janice Hopkins // BMJ: British Medical Journal (International Edition);7/26/2008, Vol. 337 Issue 7663, p197 

    The article reports on a 2008 decision from U.S. Senator Charles Grassley to ask the American Psychiatric Association (APA) to account for money it has received from pharmaceutical companies in the form of grants, donations and the sponsorship of meetings and programs. Grassley decided to ask...

  • Institutes in pharma cash probe. Ledford, Heidi // Nature;6/19/2008, Vol. 453 Issue 7198, p963 

    The article discusses a crackdown on financial conflicts of interest among researchers in the United States. Senator Charles Grassley has told Congress that three psychiatrists at Harvard Medical School may have failed to disclose a total of around $4 million of industry earnings. Grassley also...

  • Harvard panel: give 'living wage' raise.  // Food Management;Feb2002, Vol. 37 Issue 2, p12 

    Reports the recommendation made by a panel at Harvard University to raise the pay for university workers in Cambridge, Massachusetts. Terms in the recommendation; Inclusion of cafeteria workers in the proposed wage hike; Annual cost of the recommendation.

  • Group Purchasing Organizations: Research on Their Pricing Impact on Health Care Providers. Kohn, Linda T. // GAO Reports;3/1/2010, p1 

    A letter is presented from Linda T. Kohn, director of health care at the U.S. Government Accountability Office (GAO), to Senator Charles E. Grassley, ranking member of the Senate Committee on Finance, regarding the pricing impact of group purchasing organizations (GPO) on health care providers.

  • Senator introduces bill on Medicare managed care protections.  // Primary Care Weekly;05/12/97, Vol. 3 Issue 19, p3 

    Highlights US Senator Charles E. Grassley's introduction of a bill called Medicare Patient Choice and Access Act of 1997. Provisions of the legislation; Issue on comparative health plan information; Appeals of unfavorable coverage decisions; Financial incentives; Access to specialists.

  • SENATOR ASKS MEDICAL SOCIETIES TO DISCLOSE INDUSTRY PAYMENTS.  // Medical Economics;1/8/2010, Vol. 87 Issue 1, p13 

    The article offers information on the letter sent by Senator Charles Grassley to 33 medical societies urging them to disclose the financial support they received from pharmaceutical, medical device and insurance industries in the U.S.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics